"10.1371_journal.pone.0087131","plos one","2014-01-31T00:00:00Z","Dorit Lehmann; Jan Spanholtz; Caterina Sturtzel; Marleen Tordoir; Bernhard Schlechta; Dirk Groenewegen; Erhard Hofer","Department of Vascular Biology and Thrombosis Research, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria; Glycostem Therapeutics, s-Hertogenbosch, Nijmegen, The Netherlands; Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria","Conceived and designed the experiments: DL JS DG EH. Performed the experiments: DL JS CS MT BS. Analyzed the data: DL JS DG EH. Contributed reagents/materials/analysis tools: DL JS DG BS. Wrote the paper: DL DG EH.","This work relates to GBGM medium for ex-vivo generation of NK-cells, which is a commercially available cell culture medium previously developed by Glycostem Therapeutics. Purchase and/or use of GBGM medium is not restricted by patent rights. Glycostem Therapeutics has acted as sponsor in part of this research. JS and MT are employees of Glycostem Therapeutics. The other authors based at the Medical University of Vienna have no financial or commercial interest connected to Glycostem Therapeutics. All authors confirm that this does not alter their adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors. The authors agree to make freely available any materials and information associated with their publication that are reasonably requested by others for the purpose of academic, non-commercial research.","2014","01","Dorit Lehmann","DL",7,TRUE,4,5,4,3,TRUE,TRUE,FALSE,0,NA,FALSE
